Overview

Hydrotherapy for the Reversal of Oligohydramnios

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
OBJECTIVE: To assess the efficacy of subtotal immersion therapy as an option to improve maternal intravascular volume thereby improving both maternal and fetal hemodynamic status with reversal of oligohydramnios. This will be measured utilizing the Amniotic Fluid Volume (AFV) as the primary outcome. Secondary outcomes will be measured using Fetal Doppler Studies, Maternal vital signs (Blood Pressure, Pulse Pressure, Weight, Pulse) and input/output. HYPOTHESIS: Oligohydramnios, secondary to depleted maternal intravascular volume, can be reversed by improving feto- and uteroplacental perfusion with subtotal immersion therapy.
Phase:
N/A
Details
Lead Sponsor:
Mednax Center for Research, Education and Quality
Mednax Center for Research, Education, Quality and Safety
Collaborator:
Banner Health